☰

Andrei Goga

Affiliations: 
Biomedical Sciences University of California, San Francisco, San Francisco, CA 
Area:
Cell Biology, Molecular Biology, Oncology
Google:
"Andrei Goga"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Lionel Lim grad student 2013 UCSF
Noelle H. Mullin grad student 2013 UCSF

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jacobo Jacobo M, Donnella HJ, Sobti S, et al. (2024) An inflamed tumor cell subpopulation promotes chemotherapy resistance in triple negative breast cancer. Scientific Reports. 14: 3694
Navickas A, Asgharian H, Winkler J, et al. (2023) An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus. Nature Cell Biology
Komoll RM, Hu Q, Olarewaju O, et al. (2020) MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. Journal of Hepatology
Rohrberg J, Van de Mark D, Amouzgar M, et al. (2020) MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities. Cell Reports. 30: 3368-3382.e7
Vidula N, Nanda R, Miller K, et al. (2020) Immunotherapy and chemotherapy combination for chest wall disease: TBCRC 044 trial. Journal of Clinical Oncology. 38: TPS1114-TPS1114
Chien AJ, Gliwa AS, Rahmaputri S, et al. (2020) A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression. Journal of Clinical Oncology. 38: 1076-1076
Vidula N, Nanda R, Miller K, et al. (2020) Abstract OT2-04-05: Pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease: Translational Breast Cancer Research Consortium (TBCRC) 44 trial Cancer Research
Goga A, Rohrberg J, Corella A, et al. (2019) Abstract P3-09-01: MYC dysregulates mitotic spindle function in triple-negative breast cancer creating a dependency on TPX2 Cancer Research. 79
Vidula N, Goga A, Hwang J, et al. (2019) Abstract OT3-04-04: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease, with immunologic and genomic correlative studies Cancer Research. 79
Shah KN, Bhatt R, Rotow J, et al. (2019) Abstract 2902: Non-genetic TPX2/AURKA signaling facilitates tumor evolution in EGFR-TKI resistance in NSCLC Cancer Research. 79: 2902-2902
See more...